New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic

G. Rayman (Lead / Corresponding author), A. Lumb, B. Kennon, C. Cottrell, D. Nagi, E. Page, D. Voigt, H. Courtney, H Atkins, J. Platts, K. Higgins, K. Dhatariya, M. Patel, P. Narendran, P. Kar, P. Newland-Jones, O. Burr, R. Stewart, S. Thomas

Research output: Contribution to journalLetter

1 Citation (Scopus)

Abstract

The COVID-19 pandemic has had a dramatic impact on the provision of acute inpatient care with specialists from all disciplines having to manage patients outside of their usual speciality areas. In many UK hospitals diabetes consultants and diabetes inpatient specialist nurses have been redeployed to the wards to care for COVID-19 positive or suspected cases. Consequently, clinicians relatively unfamiliar with managing hyperglycaemia have been required to do so as the usual input from diabetes specialist teams has not been possible in many areas.

Original languageEnglish
Pages (from-to)1210-1213
Number of pages4
JournalDiabetic Medicine
Volume37
Issue number7
Early online date17 May 2020
DOIs
Publication statusPublished - 18 Jun 2020

Fingerprint Dive into the research topics of 'New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic'. Together they form a unique fingerprint.

  • Cite this

    Rayman, G., Lumb, A., Kennon, B., Cottrell, C., Nagi, D., Page, E., Voigt, D., Courtney, H., Atkins, H., Platts, J., Higgins, K., Dhatariya, K., Patel, M., Narendran, P., Kar, P., Newland-Jones, P., Burr, O., Stewart, R., & Thomas, S. (2020). New Guidance on Managing Inpatient Hyperglycaemia during the COVID-19 Pandemic. Diabetic Medicine, 37(7), 1210-1213. https://doi.org/10.1111/dme.14327